Our results showed that upregulation of signaling molecules such as GRP78, p-PERK, p-IRE-1α, ATF6 and ATF4 in the FFA-treated group suggested that ERS model in vitro was successfully induced by FFA. The gene discussed is HSPA5; the disease is amelogenesis imperfecta type 1G.